NCT04762485View on ClinicalTrials.gov

Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2024

Conditions
T Lymphoblastic Leukemia/LymphomaMixed Phenotype Acute LeukemiaAcute Myeloid Leukemia
Interventions
BIOLOGICAL

Humanized CD7 CAR-T cells

Split intravenous infusion of CD7 CAR-T cells \[dose escalating infusion of (0.5-10)x10\^6 CD7 CAR-T cells/kg

Trial Locations (1)

215000

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

Sponsors
All Listed Sponsors
collaborator

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

INDUSTRY

lead

The First Affiliated Hospital of Soochow University

OTHER